{"schema_version":"secwatch.filing_event.v1","accession":"0000937556-23-000185","form_type":"8-K","ticker":"MASI","cik":"0000937556","company_name":"MASIMO CORP","filed_at":"2023-07-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:37.093484+00:00","generated_at":"2026-06-13T08:01:29.960430+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Masimo pre-announces Q2 revenue $453-457M, cuts FY2023 healthcare guidance to $1.30B","bullets":["Q2 consolidated revenue $453-457M: healthcare $280-282M, non-healthcare $173-175M.","Healthcare miss due to delayed large orders, lower hospital census, elevated sensor inventory.","Non-healthcare softness extended to premium audio; Stork monitor and hearables sales strong.","Lowers FY2023 healthcare revenue floor to $1.30B (from $1.45B); non-healthcare to $800-850M.","Unrecognized Contract Revenue $1.37-1.38B (+11-12% YoY); company taking cost actions."],"urls":{"canonical":"https://secwatch.observer/filing/0000937556-23-000185","json":"https://secwatch.observer/filing/0000937556-23-000185.json","markdown":"https://secwatch.observer/filing/0000937556-23-000185.md","text":"https://secwatch.observer/filing/0000937556-23-000185.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/937556/000093755623000185/0000937556-23-000185-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/937556/000093755623000185/masi-20230717.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T08:01:29.960430+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"220309f926df1062dcf8db98301413a71cbacfcc","claim":"MASIMO CORP reported second quarter ended July 1, 2023 results: revenue consolidated revenue expected to range from $453 million to $457 million.","evidence_excerpt":"Masimo expects its consolidated revenue for the second quarter 2023 to range from $453 million to $457 million, with healthcare revenue expected to range fro m $280 million to $282 million and non-healthcare revenue expected to range fro m $173 million to $175 million .","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/937556/000093755623000185/0000937556-23-000185-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"second quarter ended July 1, 2023"},{"label":"Revenue","value":"consolidated revenue expected to range from $453 million to $457 million"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"},{"claim_id":"4df08b6a0f1bca3a9302595bf96c545ee7e37bc8","claim":"MASIMO CORP reported fiscal year 2023 results: revenue healthcare revenue guidance reduced to lower end of $1.30 billion; non-healthcare revenue guidance reduced to $800 milli. Guidance lowered.","evidence_excerpt":"We currently expect to reduce the lower end of full year revenue guidance for the healthcare business to $1.30 billion from $1.45 billion. We are still evaluating the upper end of revenue guidance for the healthcare business, but it could be materially higher than the lower end of the range, as we are still targeting our original guidance. We also expect to reduce annual revenue guidance for the non-healthcare business to $800 million to $850 million from $965 million to $995 million.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/937556/000093755623000185/0000937556-23-000185-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fiscal year 2023"},{"label":"Revenue","value":"healthcare revenue guidance reduced to lower end of $1.30 billion; non-healthcare revenue guidance reduced to $800 milli"},{"label":"Guidance","value":"lowered"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}